Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...

Various studies have pointed toward GLP-1 RAs causing mental health complications, such as anxiety and depression. The National Institutes of Health (NIH) published research in June 2024 that ...

Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...

Weight loss can reverse the cardiovascular changes that take place in the heart, but will a new diet and exercise work, or is ...

ABOUT 20 years ago, a dear pal of mine mocked me on holiday when I emerged by the pool in a pair of swim shorts. “Mate,” ...

A qualitative study reveals that providers mostly avoid stigmatizing terms but would welcome additional guidance on ...

Vivani Chief Executive Officer Adam Mendelsohn, Ph.D., stated, "Our ongoing first-in-human study, LIBERATE-1, remains on track to deliver key data in mid-2025 with the aim of validating our ...

The NHS has been urged to accelerate the rollout of weight loss drugs to “many millions” of people, as experts hailed the start of a “golden age” of anti-obesity treatments. A raft of studies ...

Type 5 diabetes, also known as malnutrition-related diabetes, is now an official diagnosis recognized by the International ...

A MUM has shared a downside of her epic weight loss transformation after being on Mounjaro for over two months. Scottish mum Kirsty took to TikTok after she shed almost a staggering 5 stone while ...

In fact, co-lead author, Dr Yael Wolff Sagy from Tel-Aviv, Israel, said researchers found a "direct effect" of GLP-1s beyond ...

GLP-1 receptor agonists are reshaping obesity care. OHE highlights access challenges, prescribing policy, and how patient and ...